Significance of Molecular Genotyping for Lung Cancer in Modern Oncology

Journal Title: Pulmonary Research and Respiratory Medicine – Open Journal - Year 2015, Vol 2, Issue 3

Abstract

Lung cancer is one of the most prevalent life-threatening diseases and remains the leading cause of cancer-related death worldwide. Although surgical resection of the tumor is considered as one of the most effective treatments, most lung cancer patients present with locally advanced or metastatic disease at the time of the diagnosis and are not candidates for surgical treatment. For these patients palliative chemotherapy and radiation therapy, alone or in combination, become the main treatment of choice. The prognosis for lung cancer in general is poor and an overall 5-year survival rate for all stages of lung cancer, regardless of subtypes, is about 18%, which has not been significantly improved in the past several decades. For those in an advanced stage of the disease the prognosis is even worse. About half of all lung cancer patients have metastatic disease at the time of diagnosis with a 5-year survival rate of less than 5%. There is no doubt that the conventional treatment of lung cancer would not significantly change the outcome for lung cancer patients.

Authors and Affiliations

Zhaolin Xu

Keywords

Related Articles

Pulmonary Rehabilitation in Patients With Pulmonary Hypertension

Traditionally, patients with pulmonary hypertension (PH) were advised to limit their physical activity because of the risk of fatal cardiovascular compromise. However, relatively little is known about the risks and benef...

Recent Advances in Pulmonary Rehabilitation for Patients with COPD

Pulmonary rehabilitation (PR) is a non-pharmacologic therapy that has emerged as a standard of care for patients with chronic obstructive pulmonary disease (COPD). It is a comprehensive, multidisciplinary, patient-center...

Significance of Molecular Genotyping for Lung Cancer in Modern Oncology

Lung cancer is one of the most prevalent life-threatening diseases and remains the leading cause of cancer-related death worldwide. Although surgical resection of the tumor is considered as one of the most effective trea...

Rehabilitation in Patients Undergoing Lung Transplantation (LTx)

Lung transplantation (LTx) has become an established therapeutic option for treating patients with end-stage pulmonary disease. Before and after LTx, physical ability might be restricted due to certain effects on respira...

Paraneoplastic Syndrome: What should Pulmonologists know?

Pulmonologists often encounter patients with oncologic emergencies (Figure 1) such as metabolic syndrome (tumor lysis syndrome),1 hypercalcemia, syndrome of inappropriate secretion of antidiuretic hormone (SIADH), hemato...

Download PDF file
  • EP ID EP550123
  • DOI 10.17140/PRRMOJ-2-119
  • Views 123
  • Downloads 0

How To Cite

Zhaolin Xu (2015). Significance of Molecular Genotyping for Lung Cancer in Modern Oncology. Pulmonary Research and Respiratory Medicine – Open Journal, 2(3), 120-121. https://europub.co.uk/articles/-A-550123